Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Standard view
Full view
of .
Look up keyword
Like this
0 of .
Results for:
No results containing your search query
P. 1
Stem Cells

Stem Cells

Ratings: (0)|Views: 163|Likes:
Published by visiongain
Stem Cells – The Hype & Hope – World Analysis 2009-2024
Stem Cells – The Hype & Hope – World Analysis 2009-2024

More info:

Published by: visiongain on Apr 21, 2009
Copyright:Attribution Non-commercial


Read on Scribd mobile: iPhone, iPad and Android.
download as DOC, PDF, TXT or read online from Scribd
See more
See less





Stem Cells – The Hype & Hope – WorldAnalysis 2009-2024
Publication date: 23/03/2009
 Number of Pages: 1551.Report Details2.Table of Contents3.Companies Listed
Report DetailsStem cell technologies – changes to US regulations to give exciting new hopes andpotentially vast commercial opportunities – brand new indepth study
Stem cells represent one of the most promising medical breakthroughs of all time, as our new market report explains. Currently, in 2009, the new US administration is lifting somemajor restrictions on stem cells technologies. This developmental obstacle now removed,all types of stem cells are available for expanding the therapeutic and commercial potentials, as our new report
Stem Cells – The Hype & Hope – World Analysis 2009-2024
explains. Based upon the cells that create and renew all tissues potentially, stem celltherapies could revolutionise the treatment of disease, especially through tissue and organreplacement. Stem cells could provide revolutionary treatments for conditions fromdiabetes to multiple sclerosis, and from myocardial infarction to chronic obstructive pulmonary disease, amongst many others. Stem cell lines could also change the way pharmaceutical companies assess new chemical entities during R&D.A conservative estimate places the potential market value of stem cells at over $150bn bylate next decade. But will stem cell products be ready to meet regulatory hurdles andmarket requirements? Where is stem cell research heading today? What stem celltherapies are likely to hit the market from 2009 onwards? Where does the highest valuelie in the short-term? What are the commercial threats there? This new visiongain report
answers these and other crucial questions about this important developing field, one withvast commercial potential.
Comprehensive analysis of the global stem cells sector and market
Stem Cells – The Hype & Hope – World Analysis 2009-2024
examines stem cellstechnology critically. We used a comprehensive review of information sources, includingconsultations with relevant experts. This report provides detailed sales forecasts,discussions of pipeline developments and analyses of important contemporary issues,especially relevant commercial drivers and restraints. This report also covers regulationsand ethics. Sources used include commercial databases, industry news, published reports, policy documents and economic research. Importantly, visiongain applied rigorousfinancial forecasting, qualitative analyses and the assessment of unmet needs. The resultis a comprehensive market- and industry-centred report with detailed analysis andinformed opinion that you will not find elsewhere.
Why you should buy this report:
Key information that you will find in
Stem Cells – The Hype & Hope – World Analysis2009-2024
includes:• Analyses of the existing market value for stem cells• Analyses of the potential market value of stem cell therapies, including detailed revenueforecasts from 2009 to 2024• Forecasts for existing stem cell markets, including private cord blood banks and OsirisTherapeutics and NuVasive’s Osteocel• Discussions of ethical complications and situations that influence the way stem cellmedicine is perceived, researched and conducted• Analyses of key organisations, suppliers and relevant national laws• Expert opinions from original research interviews with key opinion leaders in stem cellsresearch and technology• Informed analyses of the strengths and weaknesses of the technologies from 2009onwards• Balanced assessments of commercial drivers and restraints in the stem cells field.• Visiongain believes that stem cell technologies are progressing rapidly. We predict thatmore products will enter the market over the coming 5 years, changing the commerciallandscape for stem cells.
You can order this report today
 Nobody with an interest in the stem cells field can afford to overlook this new marketstudy from visiongain. The market environment in many countries will change, especiallyafter favourable developments in the US in early 2009. Visiongain predicts that revenuesfor stem cell technologies will increase greatly from 2009 to 2024, with important eventsshaping trends. Will stem cells revolutionise medicine in the foreseeable future? What arethe main obstacles to overcome there? What revenues can be achieved? This reportcovers those vital questions and many more. Do you want to know more about thisimportant market? You can stay ahead in this exciting field by ordering this report today.

You're Reading a Free Preview

/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->